IP Library Granted Patent US 11,432,576
Granted Patent B2
US 11,432,576 · App. 16/308,507 · Granted Sep 6, 2022

Heat sterilized high protein enteral compositions with whey protein which comprises whey protein micelles and a source of casein

Inventor: Giulia Marchesini (Bern, CH)
Assignee: Societe des Produits Nestle S.A.
A23L33/19A23J3/10A23L2/39A23L2/66A23L33/30A23L33/40A23J3/14A23V2002/00A23V2200/33A23V2250/5488A23V2250/54246A23V2250/54252A23V2300/24A23V2300/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,432,576
App. No.
16/308,507
Granted
Sep 6, 2022
Kind
B2
Abstract

The present invention is directed to a liquid heat sterilized enteral composition comprising: a protein source in an amount of 12 to 20% by weight of the composition, the protein source consisting of whey protein containing whey protein micelles and a source of casein. The inventive heat sterilized enteral composition preferably has a cysteine content of 1.2 to 2.4% by weight of the composition. The present invention is furthermore directed to a process for preparing a heat sterilized enteral composition comprising protein in an amount of 12 to 20% by weight based on the weight of the composition, said protein consisting of whey protein containing whey protein micelles and casein, which comprises the steps of: (i) Providing an aqueous solution of a protein source consisting of whey protein containing whey protein micelles and (ii) Adding a protein source containing casein; (iii) Optionally performing a homogenization treatment step; (iv) Performing a heat treatment step; (v) Optionally performing a homogenization treatment step. Finally, the invention concerns the use of a protein source consisting of whey protein containing whey protein micelles and a source of casein, for preparing an enteral composition and/or for controlling the viscosity of a liquid enteral composition, wherein the enteral composition comprises 12 to 20 weight % total protein. The invention also concerns medical uses and treatments applying or using the inventive heat sterilized enteral composition.

Claims (29)

1. A liquid heat sterilized enteral composition comprising:

a protein source in an amount of 12 to 20% by weight of the enteral composition, the protein source consisting of whey protein containing whey protein micelles, and a source of casein;

wherein the weight ratio of the casein to the whey protein is in the range of 35:65 to 65:35; and

wherein the enteral composition contains cysteine in an amount of 1.2 to 2.4% by weight of the protein source.

2. The enteral composition according to claim 1 , wherein the whey protein is present in an amount of 4.5 to 9% by weight of the enteral composition.

3. The enteral composition according to claim 1 , wherein the casein is present in an amount of 3.5 to 13% by weight of the enteral composition.

4. The enteral composition according to claim 1 , wherein the enteral composition is a liquid composition having a viscosity below 200 mPa·s at 20° C. measured at a shear rate of 100 s −1 .

5. The enteral composition according to claim 1 , having a protein concentration of up to 20 g/100 g of the enteral composition.

6. The enteral composition according to claim 1 , which is in a form selected from the group consisting of a nutritional composition, a nutritional supplement, an infant formula, a follow-up formula, a baby food formula, an infant cereal formula or a growing-up milk, an infant or child's food supplement, a children formula, an adult nutritional composition, a maternal nutritional supplement, a bariatric formula, an elderly nutritional composition and a health care formula.

7. A liquid enteral composition comprising 12 to 20 weight % total protein based on the weight of the liquid enteral composition, the total protein consisting of whey protein containing whey protein micelles, and a source of casein for controlling the viscosity of the liquid enteral composition,

wherein the weight ratio of the casein to the whey protein is in the range of 35:65 to 65:35, and

wherein the liquid enteral composition has a pH of 6 to 8, and the liquid enteral composition contains cysteine in an amount of 1.2 to 2.4% by weight of the total protein.

8. A process for preparing a liquid heat sterilized enteral composition comprising total protein in an amount of 12 to 20% by weight of the liquid enteral composition, the total protein comprising casein and whey protein containing whey protein micelles,

wherein the weight ratio of the casein to the whey protein is in the range of 35:65 to 65:35,

the process comprising:

(i) providing an aqueous solution of a protein source comprising whey protein containing whey protein micelles;

(ii) adding a protein source containing casein; and

(iii) performing a ultra-high temperature (UHT) heat treatment step above 140° C.

9. The process according to claim 8 , wherein the whey protein is present in an amount of 4.5 to 9% by weight of the enteral composition.

10. The process according to claim 8 , wherein the casein is present in an amount of 3.5 to 13% by weight of the enteral composition.

11. The process according to claim 8 , wherein the liquid heat sterilized enteral composition has a viscosity below 200 mPa·s at 20° C. measured at a shear rate of 100 s −1 .

12. The process according to claim 8 , further comprising drying to form a powder.

13. The process according to claim 8 , wherein the total protein consists of casein and whey protein containing whey protein micelles.

14. The process according to claim 8 , wherein the liquid enteral composition contains cysteine in an amount of 1.2 to 2.4% by weight of the total protein.

15. The process according to claim 8 , wherein the UHT heat treatment is performed at 141-160° C.

16. The enteral composition according to claim 1 , wherein the enteral composition contains cysteine in an amount of 1.8 to 2.2% by weight of the protein source.

17. The enteral composition according to claim 1 , wherein the weight ratio of casein to whey protein is in the range of 45:55 to 55:45.

18. The enteral composition according to claim 1 , wherein the whey protein micelles is present in an amount of 2.5 to 3.5% by weight of the enteral composition.

19. The enteral composition according to claim 7 , wherein the liquid enteral composition has a pH of 6.7 to 6.9.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: MARCHESINI, GIULIA
To: NESTEC S.A.
Reel/Frame 049881/0045 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →